Palace assures Sinovac vaccine safety, effectiveness

Malacañang has affirmed the safety and effectiveness of the Sinovac COVID-19 vaccine, with China's Sinovac Biotech expected to provide 25 million doses to the Philippines this year.

Presidential spokesperson Harry Roque cited clinical trial results from Turkey indicating the CoronaVac vaccine's 91.25% efficacy rate.

Roque noted that neighboring countries like Indonesia and Thailand have also entered into supply agreements with Sinovac.

He explained that the Sinovac vaccine utilizes an inactivated virus, a traditional method used in vaccine development for centuries, assuring its safety and efficiency.

Roque expressed hope that China might donate some vaccine doses due to the strong bilateral relations between the two nations.

He also criticized detractors spreading fear about Chinese vaccines, emphasizing that Sinovac has undergone rigorous clinical trials in various countries.

Topics in this story

Explore more stories about these topics.

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.

News Sources

See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.